June 13, 2017 / 11:15 AM / 2 months ago

BRIEF-Intrexon, Johnson Matthey collaborate on production of peptide-based pharmaceutical ingredients

June 13 (Reuters) - Intrexon Corporation:

* Intrexon and Johnson Matthey collaborate on fermentative production of peptide-based active pharmaceutical ingredients

* Under terms, JM will have access to co's technologies and expertise for microbe-based fermentative production of specific target apis

* Agreement also provides for milestone payments to Intrexon, as well as royalties based on net sales of commercialized products

* Intrexon Corporation says Intrexon will receive a technology access fee and reimbursement for all research and development costs

* Through collaboration, co to utilize proprietary microbial hosts, fermentation processes for expression of peptides with high fidelity, titer Source text for Eikon: Further company coverage: and

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below